Currently the Enterprise Value (EV) is not available for Avadel Pharmaceuticals.
n/a
n/a
n/a
n/a
Financial Position
The company has a current ratio of 2.75,
with a Debt / Equity ratio of 0.02.
2.75
2.33
0.02
-0.05
-0.04
-3.91
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
n/a
n/a
n/a
$899.56K
$-259.74K
188
1.03
0.75
Taxes
-247K
0.5%
Stock Price Statistics
The stock price has increased by 2.46% in the
last 52 weeks. The beta is 1.58, so Avadel Pharmaceuticals's
price volatility has been higher than the market average.
1.58
2.46%
11.77
9.7
70.29
1,398,172
Income Statement
In the last 12 months, Avadel Pharmaceuticals had revenue of 169.12M
and earned -48.83M
in profits. Earnings per share was -0.51.